1-(4-Fluoro-benzyl)-4-methyl-2-oxo-imidazolidine-4-carboxylic acid | 880468-23-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 1-(4-Fluoro-benzyl)-4-methyl-2-oxo-imidazolidine-4-carboxylic acid
• 英文别名: 1-[(4-Fluorophenyl)methyl]-4-methyl-2-oxoimidazolidine-4-carboxylic acid
• CAS: 880468-23-5
• 化学式: C₁₂H₁₃FN₂O₃
• 分子量: 252.245
• InChiKey: INUCAURFLKICPT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  69.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-(4-Fluoro-benzyl)-4-methyl-2-oxo-imidazolidine-4-carboxylic acid 在 草酰氯 、 三乙胺 、 N,N-二甲基甲酰胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 生成 N-[4-cyano-3-(trifluoromethyl)phenyl]-1-[(4-fluorophenyl)methyl]-4-methyl-2-oxoimidazolidine-4-carboxamide
  参考文献：
  名称：

  A bioisosteric approach to the discovery of indole carbinol androgen receptor ligands

  摘要：

  Two potential bioisosteres of the nonsteroidal antiandrogen bicalutamide, an imidazolidinone and an indole, were synthesized and tested for their androgen receptor binding. Indole was discovered to be a suitable bioisostere for the acyl anilide moiety in the parent compound. Several analogs in the indole series were found to be 10-fold better than bicalutamide in binding to the recombinant androgen receptor binding domain. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.08.036
• 作为产物：
  描述：

  1-(4-Fluoro-benzyl)-4-methyl-2-oxo-imidazolidine-4-carboxylic acid methyl ester 在 sodium hydroxide 作用下， 以 甲醇 为溶剂， 生成 1-(4-Fluoro-benzyl)-4-methyl-2-oxo-imidazolidine-4-carboxylic acid
  参考文献：
  名称：

  A bioisosteric approach to the discovery of indole carbinol androgen receptor ligands

  摘要：

  Two potential bioisosteres of the nonsteroidal antiandrogen bicalutamide, an imidazolidinone and an indole, were synthesized and tested for their androgen receptor binding. Indole was discovered to be a suitable bioisostere for the acyl anilide moiety in the parent compound. Several analogs in the indole series were found to be 10-fold better than bicalutamide in binding to the recombinant androgen receptor binding domain. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.08.036

文献信息

• Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS)
  申请人：Lanter C. James

  公开号：US20060063819A1

  公开（公告）日：2006-03-23

  The present invention is directed to novel imidazolidin-2-one derivatives having a structure according to Formula I wherein a, b, R 1 , R 2 , R 3 , and R 4 are as defined above, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.

  本发明涉及具有公式I结构的新型咪唑啉-2-酮衍生物，其中a、b、R1、R2、R3和R4的定义如上所述，以及包含它们的制药组合物和它们在治疗通过雄激素受体调节的疾病和症状中的应用。
• NOVEL IMIDAZOLIDIN-2-ONE DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS)
  申请人：JANSSEN PHARMACEUTICA N.V.

  公开号：EP1791821A2

  公开（公告）日：2007-06-06
• US7531565B2
  申请人：——

  公开号：US7531565B2

  公开（公告）日：2009-05-12
• [EN] NOVEL IMIDAZOLIDIN-2-ONE DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS)<br/>[FR] DERIVES D'IMIDAZOLIDINE-2-ONE EN TANT QUE MODULATEURS SELECTIFS DU RECEPTEUR ANDROGENIQUE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2006031715A2

  公开（公告）日：2006-03-23

  The present invention is directed to novel imidazolidin-2-one derivatives having a structure according to Formula I, wherein a, b, R1, R2, R3, and R4 are as defined above, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.